Autopsy report · NCT03812562
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
Cause of deathFunding or business
“Lack of funding”
Life of this trial
- Ran for about 4 years 8 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Early Phase 1
- Sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Nivolumab; Yttrium Y 90 Glass Microspheres
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.